Fresenius Kabi Compounding, LLC recalls NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 4 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile
Recalled October 30, 2024 · FDA recall D-0019-2025 · Fresenius Kabi Compounding
Hazard
cGMP violations · FDA Class II
Units
2151 bags
Sold at
Product was distributed to 125 direct accounts nationwide.
Description
cGMP violations
Product
NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 4 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-025-58
Manufacturer(s)
Fresenius Kabi Compounding, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →